天宇股份：11月18日召开董事会会议

Core Viewpoint - Tianyu Co., Ltd. announced the convening of its fifth board meeting on November 18, 2025, to review various proposals, including the confirmation of the audit committee members and the convener [1] Company Overview - For the first half of 2025, Tianyu Co., Ltd.'s revenue composition is as follows: 72.18% from generic drug raw materials and intermediates, 16.02% from CDMO raw materials and intermediates, 11.43% from formulations, and 0.37% from other sources [1] - As of the report date, the market capitalization of Tianyu Co., Ltd. is 9.2 billion yuan [1]